CBG.L vs. JBIO

Last updated Jul 21, 2026

CBG.L (Close Brothers Group plc) and JBIO (Jade Biosciences, Inc) are both stocks. CBG.L operates in Banks - Regional (Financial Services), while JBIO operates in Biotechnology (Healthcare). Over the past 5 years, CBG.L returned -20.09%/yr vs 68.50%/yr for JBIO. At a 0.08 correlation, their price movements are largely independent.

Performance

CBG.L vs. JBIO - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in Close Brothers Group plc (CBG.L) and Jade Biosciences, Inc (JBIO). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

CBG.L is traded in GBp, while JBIO is traded in USD. To make them comparable, the JBIO values have been converted to GBp using the latest available exchange rates.

Returns By Period

In the year-to-date period, CBG.L achieves a -20.88% return, which is significantly lower than JBIO's 27.86% return.

CBG.L

• 1D: 0.44%
• 1M: -8.86%
• 6M: -21.26%
• YTD: -20.88%
• 1Y: 0.73%
• 3Y*: -22.69%
• 5Y*: -20.09%
• 10Y*: -6.53%
• ALL TIME*: -0.01%

JBIO

• 1D: -5.56%
• 1M: 14.99%
• 6M: 33.24%
• YTD: 27.86%
• 1Y: 107.52%
• 3Y*: 119.69%
• 5Y*: 68.50%
• 10Y*: —
• ALL TIME*: 46.64%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CBG.L vs. JBIO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
CBG.L Close Brothers Group plc	-20.88%	121.21%	-70.25%	-17.80%	-20.21%	-5.16%
JBIO Jade Biosciences, Inc	27.86%	5,076.05%	-88.09%	-26.62%	178.06%	-56.98%

Correlation

The correlation between CBG.L and JBIO is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.17
Correlation (3Y) Calculated over the trailing 3-year period	0.12
Correlation (5Y) Calculated over the trailing 5-year period	0.09
Correlation (All Time) Calculated using the full available price history since Jun 30, 2021	0.08

Fundamentals

Market Cap CBG.L : £623.05M JBIO : $641.75M
EPS CBG.L : -£0.82 JBIO : -$2.65
PB Ratio CBG.L : 0.42 JBIO : 3.83
Total Revenue (TTM) CBG.L : £1.84B JBIO : $0.00
Gross Profit (TTM) CBG.L : £1.58B JBIO : -$9.00K
EBITDA (TTM) CBG.L : £174.70M JBIO : -$133.57M

Return for Risk

CBG.L vs. JBIO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CBG.L

CBG.L Risk / Return Rank: 45
CBG.L Sharpe Ratio Rank: 46
CBG.L Sortino Ratio Rank: 45
CBG.L Omega Ratio Rank: 45
CBG.L Calmar Ratio Rank: 46
CBG.L Martin Ratio Rank: 45

JBIO

JBIO Risk / Return Rank: 83
JBIO Sharpe Ratio Rank: 84
JBIO Sortino Ratio Rank: 82
JBIO Omega Ratio Rank: 80
JBIO Calmar Ratio Rank: 83
JBIO Martin Ratio Rank: 85

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CBG.L vs. JBIO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Close Brothers Group plc (CBG.L) and Jade Biosciences, Inc (JBIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	CBG.L	JBIO	Difference
Sharpe ratio: Return per unit of total volatility	0.01	1.42	-1.41
Sortino ratio: Return per unit of downside risk	0.42	2.14	-1.72
Omega ratio: Gain probability vs. loss probability	1.05	1.26	-0.20
Calmar ratio: Return relative to maximum drawdown	0.02	2.49	-2.47
Martin ratio: Return relative to average drawdown	0.04	6.96	-6.92

CBG.L vs. JBIO - Sharpe Ratio Comparison

The current CBG.L Sharpe Ratio is 0.01, which is lower than the JBIO Sharpe Ratio of 1.42. The chart below compares the historical Sharpe Ratios of CBG.L and JBIO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

CBG.L vs. JBIO - Drawdown Comparison

The maximum CBG.L drawdown since its inception was -86.76%, smaller than the maximum JBIO drawdown of -95.54%. Use the drawdown chart below to compare losses from any high point for CBG.L and JBIO.

Drawdown Indicators

	CBG.L	JBIO	Difference
Max Drawdown Largest peak-to-trough decline	-86.76%	-95.54%	+8.78%
Max Drawdown (1Y) Largest decline over 1 year	-37.33%	-43.38%	+6.05%
Max Drawdown (3Y) Largest decline over 3 years	-79.32%	-95.47%	+16.15%
Max Drawdown (5Y) Largest decline over 5 years	-86.23%	-95.54%	+9.31%
Max Drawdown (10Y) Largest decline over 10 years	-86.76%	—	—
Current Drawdown Current decline from peak	-70.41%	-26.18%	-44.23%
Average Drawdown Average peak-to-trough decline	-23.54%	-43.97%	+20.43%
Ulcer Index Depth and duration of drawdowns from previous peaks	17.73%	16.56%	+1.17%

Volatility

CBG.L vs. JBIO - Volatility Comparison

The current volatility for Close Brothers Group plc (CBG.L) is 15.58%, while Jade Biosciences, Inc (JBIO) has a volatility of 23.36%. This indicates that CBG.L experiences smaller price fluctuations and is considered to be less risky than JBIO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CBG.L	JBIO	Difference
Volatility (1M) Calculated over the trailing 1-month period	15.58%	23.36%	-7.78%
Volatility (6M) Calculated over the trailing 6-month period	36.22%	54.36%	-18.14%
Volatility (1Y) Calculated over the trailing 1-year period	51.23%	76.19%	-24.96%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	49.44%	1,585.59%	-1,536.15%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	39.92%	1,576.89%	-1,536.97%

Dividends

CBG.L vs. JBIO - Dividend Comparison

Neither CBG.L nor JBIO has paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CBG.L Close Brothers Group plc	0.00%	0.00%	0.00%	8.50%	6.30%	4.27%	4.54%	4.13%	4.38%	4.14%	3.94%	4.00%
JBIO Jade Biosciences, Inc	0.00%	15.55%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both CBG.L and JBIO in my portfolio?

CBG.L and JBIO have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.